Cao Pharmaceuticals Inc.
  • Home
  • About
    • Background
    • Mission
    • Leadership
  • Products
    • Lead Drug
    • Unique Advantages
    • Pipeline
  • Contact
  • Investor Relations
Picture
Products
Cao Pharmaceuticals is currently developing their lead drug, CZ48, in Phase I clinical trials. This drug, along with their pipeline drugs, enjoy many unique advantages associated with CPT based drugs derived from a natural plant extract. Promising pipeline drugs include the redesign of a currently FDA approved CPT based drug, along with others designed with specific physiochemical properties.
Products - Lead Drug
Products - Unique Advantages
Products - Pipeline

Skill One

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusant doloremque laudantium, totam rem.
Learn More
Proudly powered by Weebly
  • Home
  • About
    • Background
    • Mission
    • Leadership
  • Products
    • Lead Drug
    • Unique Advantages
    • Pipeline
  • Contact
  • Investor Relations